谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase Ib Study of a Novel C-Met, AXL and VEGFR-2 Inhibitor Ningetinib and Gefitinib Combination Therapy in Chinese EGFR-TKI Resistant NSCLC with T790M Negative.

Hongyun Zhao,Lianke Liu,Yuxiang Ma,Jian Fang,Wenfeng Fang,Haiqing Ma,Yang Zhang,Guosheng Feng,Shaodong Hong,Shan Zeng,Bo Xie,Jun Ren,Xiaoyan Lin,Yingjun Zhang,Ning Xi,Yingzhi Jiang,Yanjun Wu,Ning Kang,Su Li,Li Zhang

Journal of Clinical Oncology（2020）

引用 1|浏览110
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要